{"id":"W2047725399","doi":"10.1016/j.clml.2013.03.020","title":"Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib","year":2013,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center; Teva Pharmaceutical Industries","keywords":"Medicine; Nilotinib; Dasatinib; Internal medicine; Adverse effect; Gastroenterology; Imatinib; Neutropenia; Clinical endpoint; Confidence interval; Myeloid leukemia; Surgery; Randomized controlled trial; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008092487,0.001967635,0.003341255,0.0006944714,0.0004334437,0.0002195831,0.0008459477,0.001086297,0.001386652],"category_scores_gemma":[0.0007875328,0.0013277,0.0005391811,0.002166379,0.001158472,0.0009255944,0.0004928806,0.001328968,0.0007192899],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03996072,"about_ca_system_score_gemma":0.01211997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002370193,"about_ca_topic_score_gemma":0.001044088,"domain_scores_codex":[0.9888446,0.0004825388,0.003475092,0.002730084,0.001753605,0.002714122],"domain_scores_gemma":[0.9925215,0.001002599,0.001425171,0.002530783,0.0008419021,0.001678054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02204357,0.003371256,0.2982164,0.001096101,0.001317882,0.008062768,0.0004073153,0.0003187657,0.001164955,0.0000240643,0.00264423,0.6613327],"study_design_scores_gemma":[0.1355815,0.02763649,0.8147627,0.004025148,0.001079184,0.001267489,0.00009882828,0.007320164,0.004031985,0.00001847941,0.002250124,0.001927967],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893976,0.001480344,0.00003387846,0.0004677458,0.0002949927,0.006797374,0.00008972389,0.0006822905,0.0007560943],"genre_scores_gemma":[0.9914393,0.0004144385,0.001907324,0.0006327906,0.0009223809,0.0009328321,0.001071456,0.000492678,0.002186764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6594048,"threshold_uncertainty_score":0.9995262,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01974581216089715,"score_gpt":0.3045457770249775,"score_spread":0.2847999648640803,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}